12.11.2012 Views

FORM 10-K - Harman

FORM 10-K - Harman

FORM 10-K - Harman

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CONSOLIDATED STATEMENTS OF CASH FLOWS<br />

HARMAN INTERNATIONAL INDUSTRIES, INCORPORATED AND SUBSIDIARIES<br />

(in thousands)<br />

Cash flows from operating activities:<br />

2009<br />

Year Ended June 30,<br />

2008 2007<br />

Net (loss) income ..........................................<br />

Adjustments to reconcile net (loss) income to net cash provided by<br />

operating activities:<br />

$(422,551) $ <strong>10</strong>7,786 $ 313,963<br />

Goodwill impairment ....................................... 330,563 — —<br />

Depreciation and amortization ................................ 147,457 152,342 127,162<br />

Deferred income tax benefit .................................. (<strong>10</strong>2,871) (<strong>10</strong>,441) (45,563)<br />

(Gain) loss on disposition of assets ............................ (13,753) 235 959<br />

Share-based compensation ................................... 9,770 23,148 15,418<br />

Excess tax benefits from share-based payment arrangements ........<br />

Changes in operating assets and liabilities:<br />

Decrease (increase) in:<br />

(126) (5,321) (<strong>10</strong>,456)<br />

Receivables ........................................... 119,096 (34,980) (20,314)<br />

Inventories ........................................... 27,756 <strong>10</strong>2,451 (92,024)<br />

Other current assets ....................................<br />

Increase (decrease) in:<br />

64,036 (55,950) (34,844)<br />

Accounts payable ...................................... (81,444) (38,265) 26,266<br />

Accrued warranties ..................................... (<strong>10</strong>,304) 78,829 (12,620)<br />

Accrued other liabilities ................................. 13,056 69,785 (24,677)<br />

Income taxes payable ................................... 1,503 (63,666) (34,083)<br />

Other operating activities ................................ (3,528) (9,144) 6,126<br />

Net cash provided by operating activities ........................... 78,660 316,809 215,313<br />

Cash flows from investing activities:<br />

Contingent purchase price consideration ........................ (7,443) (12,724) (9,229)<br />

Proceeds from asset dispositions .............................. 22,882 1,476 3,038<br />

Capital expenditures ........................................ (79,850) (138,934) (174,794)<br />

Other items, net ........................................... (2,601) 7,697 970<br />

Net cash used in investing activities ............................... (67,012) (142,485) (180,015)<br />

Cash flows from financing activities:<br />

Net increase (decrease) in long-term borrowings ................. 935 (1,838) 135<br />

Net borrowings under revolving credit facility ................... 235,000 (38,940) (<strong>10</strong>7,631)<br />

Repayments under revolving credit facility ...................... (38,000) — —<br />

Repayments of long-term debt ................................ — (18,140) (18,782)<br />

Proceeds from issuance of convertible senior notes ............... — 400,000 —<br />

Issuance (repurchase) of common stock ........................ 189,723 (400,287) (128,780)<br />

Dividends paid to shareholders ............................... (2,207) (3,056) (3,262)<br />

Share-based payment arrangements ............................ 142 (3,152) 25,115<br />

Debt issuance costs ......................................... (9,733) (4,750) —<br />

Excess tax benefits from share-based payment arrangements ........ 126 5,321 <strong>10</strong>,456<br />

Net cash provided by (used in) financing activities ................ 375,986 (64,842) (222,749)<br />

Effect of exchange rate changes on cash ........................ (20,174) 7,486 1,834<br />

Net increase (decrease) in cash and cash equivalents .............. 367,459 116,968 (185,617)<br />

Cash and cash equivalents at beginning of period ................. 223,<strong>10</strong>9 <strong>10</strong>6,141 291,758<br />

Cash and cash equivalents at end of period ...................... $590,568 $ 223,<strong>10</strong>9 $ <strong>10</strong>6,141<br />

See accompanying notes to consolidated financial statements.<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!